F19.231
Other psychoactive substance dependence with withdrawal delirium
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code F19.231 refers to a condition characterized by dependence on psychoactive substances, such as drugs that affect the brain, combined with withdrawal delirium. This condition occurs when someone who has developed a dependence on these substances suddenly reduces or stops their use, leading to severe mental and physical symptoms. Withdrawal delirium involves a confused state, agitation, hallucinations, and impaired consciousness that makes it a serious medical concern requiring prompt attention. Recognizing this condition is vital for managing the withdrawal process safely and effectively.
Causes & Symptoms
Clinical Causes: Prolonged and regular use of psychoactive substances like alcohol, sedatives, opioids, or stimulants. Sudden cessation or reduction of substance intake after a period of dependence. Inadequate or lack of medical supervision during withdrawal from dependent substances. Underlying health issues that may exacerbate withdrawal symptoms.
Key Symptoms: Altered mental state, including confusion and disorientation Hallucinations, often visual but sometimes auditory or tactile Severe agitation and restlessness Fluctuating levels of consciousness or alertness Tremors and muscle rigidity Autonomic instability, such as rapid heartbeat, sweating, and increased blood pressure Sleep disturbances or insomnia Potential seizures or convulsions during severe cases
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a comprehensive clinical evaluation by a healthcare professional, including a detailed medical history of substance use and withdrawal episodes. The clinician will assess mental status and look for signs of delirium. Additional tests, such as blood work and neurological examinations, may be conducted to rule out other conditions and confirm the diagnosis. Observation during the withdrawal process is essential because delirium can progress rapidly and may require immediate intervention.
Treatment Protocols: Treatment focuses on safely managing withdrawal symptoms and preventing complications. Approaches include:
Clinical Advice & FAQs
Billing Guidance
Is F19.231 a billable ICD-10 code?
Yes, F19.231 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F19.231?
Clinical documentation must specify the nature of Other psychoactive substance dependence with withdrawal delirium and any associated comorbidities for accurate reporting.
Cite this Clinical Reference